Paper29904166
Pharmacological activation of epidermal growth factor receptor signaling inhibits colitis-associated cancer in mice.
Dubé PE and 4 others. Sci Rep, 2018. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Pharmacological activation of epidermal growth factor receptor signaling inhibits colitis-associated cancer in mice. Papers, record 29904166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29904166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colitis | Major topic |
| Colonic Neoplasms | Major topic |
| ErbB Receptors | Major topic |
| Neoplasm Proteins | Major topic |
| Neoplasms, Experimental | Major topic |
| Signal Transduction | Major topic |
| Animals | |
| Azoxymethane | |
| Dextran Sulfate | |
| Epidermal Growth Factor | |
| Mice |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 DK108648 | NIDDK NIH HHS | United States | R01DK108648 | PubMed and NIH | NIH RePORTER |
| P30 DK058404 | NIDDK NIH HHS | United States | P30DK058404 | PubMed and NIH | NIH RePORTER |
| R01 DK054993 | NIDDK NIH HHS | United States | R01DK054993 | PubMed and NIH | NIH RePORTER |
| R01 DK056008 | NIDDK NIH HHS | United States | R01DK056008 | PubMed and NIH | NIH RePORTER |
| P50 CA236733 | NCI NIH HHS | United States | P50CA236733 | PubMed | NIH RePORTER |
References84
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28400195 | EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients. | Gastroenterology | 2017 | https://conductscience.org/library/papers/28400195 | PubMed |
| 2 | 1612477 | Immunoreactivity of transforming growth factor alpha in the normal adult gastrointestinal tract. | Gut | 1992 | https://conductscience.org/library/papers/1612477 | PubMed |
| 3 | 2806986 | Distribution and release of epidermal growth factor in man. | Gut | 1989 | https://conductscience.org/library/papers/2806986 | PubMed |
| 4 | 21677747 | Genetics and pathogenesis of inflammatory bowel disease. | Nature | 2011 | https://conductscience.org/library/papers/21677747 | PubMed |
| 5 | 12047962 | Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. | Lancet | 2002 | https://conductscience.org/library/papers/12047962 | PubMed |
| 6 | 10388532 | Role of epidermal growth factor receptor in basal and stimulated colonic epithelial cell migration in vitro. | Exp Cell Res | 1999 | https://conductscience.org/library/papers/10388532 | PubMed |
| 7 | 22842618 | Mucosal healing in inflammatory bowel diseases: a systematic review. | Gut | 2012 | https://conductscience.org/library/papers/22842618 | PubMed |
| 8 | 21606592 | Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. | J Clin Invest | 2011 | https://conductscience.org/library/papers/21606592 | PubMed |
| 9 | 15284022 | Metalloprotease disintegrin-mediated ectodomain shedding of EGFR ligands promotes intestinal epithelial restitution. | Am J Physiol Gastrointest Liver Physiol | 2004 | https://conductscience.org/library/papers/15284022 | PubMed |
| 10 | 22691166 | Expression of pleiotrophin, an important regulator of cell migration, is inhibited in intestinal epithelial cells by treatment with non-steroidal anti-inflammatory drugs. | Growth Factors | 2012 | https://conductscience.org/library/papers/22691166 | PubMed |
| 11 | 19404270 | Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. | Nat Rev Gastroenterol Hepatol | 2009 | https://conductscience.org/library/papers/19404270 | PubMed |
| 12 | 22772467 | Epidermal growth factor receptor inhibits colitis-associated cancer in mice. | J Clin Invest | 2012 | https://conductscience.org/library/papers/22772467 | PubMed |
| 13 | 18281595 | Drug-induced alterations to gene and protein expression in intestinal epithelial cell 6 cells suggest a role for calpains in the gastrointestinal toxicity of nonsteroidal anti-inflammatory agents. | J Pharmacol Exp Ther | 2008 | https://conductscience.org/library/papers/18281595 | PubMed |
| 14 | 23964937 | Tumor necrosis factor inhibitors for inflammatory bowel disease. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23964937 | PubMed |
| 15 | 11521988 | Corticosteroids impair intestinal epithelial wound repair mechanisms in vitro. | Scand J Gastroenterol | 2001 | https://conductscience.org/library/papers/11521988 | PubMed |
| 16 | 21530745 | Epidemiology and natural history of inflammatory bowel diseases. | Gastroenterology | 2011 | https://conductscience.org/library/papers/21530745 | PubMed |
| 17 | 23986515 | CXCR2 knockout mice are protected against DSS-colitis-induced acute kidney injury and inflammation. | Am J Physiol Renal Physiol | 2013 | https://conductscience.org/library/papers/23986515 | PubMed |
| 18 | 19079198 | IL-23 and Th17 cytokines in intestinal homeostasis. | Mucosal Immunol | 2008 | https://conductscience.org/library/papers/19079198 | PubMed |
| 19 | 28164724 | JAK inhibition in inflammatory bowel disease. | Expert Rev Clin Immunol | 2017 | https://conductscience.org/library/papers/28164724 | PubMed |
| 20 | 23964932 | Vedolizumab as induction and maintenance therapy for ulcerative colitis. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23964932 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42737846 | Drosophila melanogaster as a Model for Gastrointestinal Radiation Injury: Conserved Mechanisms, Experimental Approaches, and Countermeasure Discovery. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737846 | PubMed |
| 41550766 | Integrative analysis of transcriptomic data reveals a predictive gene signature for chemoradiotherapy response in rectal cancer. | iScience | 2026 | https://conductscience.org/library/papers/41550766 | PubMed |
| 40952277 | Effect of Alpha1 Antitrypsin on PD-1/PD-L1 and EGFR in Colitis-Associated Colorectal Cancer BALB/c Mouse Model | Asian Pac J Cancer Prev | 2025 | https://conductscience.org/library/papers/40952277 | PubMed |
| 40641492 | A Case Report on the Development of Ulcerative Colitis During Osimertinib Therapy for Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer. | Respirol Case Rep | 2025 | https://conductscience.org/library/papers/40641492 | PubMed |
| 40406132 | Airway epithelial cell-specific deletion of EGFR modulates mucoinflammatory features of cystic fibrosis-like lung disease in mice. | Front Immunol | 2025 | https://conductscience.org/library/papers/40406132 | PubMed |
| 39230095 | Improvement effect of compound Ento-PB on oxazolone-induced ulcerative colitis in rats. | Acta Cir Bras | 2024 | https://conductscience.org/library/papers/39230095 | PubMed |
| 38723513 | Erlotinib suppresses tumorigenesis in a mouse model of colitis-associated cancer. | Biomed Pharmacother | 2024 | https://conductscience.org/library/papers/38723513 | PubMed |
| 38196993 | Casuarina glauca branchlets' extract as a potential treatment for ulcerative colitis: chemical composition, in silico and in vivo studies. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/38196993 | PubMed |
| 38045189 | Moutai Distiller's grains Polyphenol extracts and rutin alleviate DSS-induced colitis in mice: Modulation of gut microbiota and intestinal barrier function (R2). | Heliyon | 2023 | https://conductscience.org/library/papers/38045189 | PubMed |
| 37815870 | Claudin-2 protects against colitis-associated cancer by promoting colitis-associated mucosal healing. | J Clin Invest | 2023 | https://conductscience.org/library/papers/37815870 | PubMed |
| 37652012 | Wound-healing plasticity enables clonal expansion of founder progenitor cells in colitis. | Dev Cell | 2023 | https://conductscience.org/library/papers/37652012 | PubMed |
| 37107231 | Selenoprotein W Ameliorates Experimental Colitis and Promotes Intestinal Epithelial Repair. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37107231 | PubMed |
| 35628865 | Chemically Induced Colitis-Associated Cancer Models in Rodents for Pharmacological Modulation: A Systematic Review. | J Clin Med | 2022 | https://conductscience.org/library/papers/35628865 | PubMed |
| 34539797 | Active Ingredients and Potential Mechanisms of the Gan Jiang-Huang Qin-Huang Lian-Ren Shen Decoction against Ulcerative Colitis: A Network Pharmacology and Molecular Docking-Based Study. | Evid Based Complement Alternat Med | 2021 | https://conductscience.org/library/papers/34539797 | PubMed |
| 34260310 | Persistence of Lgr5+ colonic epithelial stem cells in mouse models of inflammatory bowel disease. | Am J Physiol Gastrointest Liver Physiol | 2021 | https://conductscience.org/library/papers/34260310 | PubMed |
| 34126257 | Epithelial wound healing in inflammatory bowel diseases: the next therapeutic frontier. | Transl Res | 2021 | https://conductscience.org/library/papers/34126257 | PubMed |
| 33976143 | Critical role of interferons in gastrointestinal injury repair. | Nat Commun | 2021 | https://conductscience.org/library/papers/33976143 | PubMed |
| 31002683 | Fluid supplementation accelerates epithelial repair during chemical colitis. | PLoS One | 2019 | https://conductscience.org/library/papers/31002683 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AREG | 374 | PubTator's text mining | https://conductscience.org/library/genes/374 | NCBI Gene |
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| EREG | 2069 | PubTator's text mining | https://conductscience.org/library/genes/2069 | NCBI Gene |
| ERRFI1 | 54206 | PubTator's text mining | https://conductscience.org/library/genes/54206 | NCBI Gene |
| HBEGF | 1839 | PubTator's text mining | https://conductscience.org/library/genes/1839 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29904166
GET https://conductscience.org/api/papers/v1/29904166/references?page=2